CONDITIONS
Fibromyalgia Syndrome (FMS)
Fibromyalgia feels widespread and all-consuming. Fatigue, pain everywhere, and symptoms that seem completely disconnected from one another. The challenge is that fibromyalgia is labeled as a syndrome, not a disease, which means it describes a collection of symptoms without necessarily identifying what is driving them. NMF Science investigates whether fibromyalgia often masks specific, identifiable neuromyofascial and neuropathic drivers in the spine and limbs. When those drivers are found and mapped precisely, they become the foundation for more targeted, lasting care.
Current Medical Understanding
Fibromyalgia is typically described as widespread chronic pain accompanied by fatigue, sleep disturbance, and cognitive difficulties often referred to as brain fog. The condition is diagnosed using symptom criteria established by the American College of Rheumatology, involving tender point testing and symptom questionnaires. Standard treatments include anti-inflammatory medications, antidepressants, physical therapy, and lifestyle modifications.
Many people improve only partially with these approaches. MRI imaging often shows mild degenerative changes but rarely reveals pathology severe enough to fully explain the extent of symptoms. Because imaging frequently appears normal or near normal, fibromyalgia has historically been described as a centralized pain condition, meaning the problem is attributed to how the brain processes pain rather than to identifiable tissue pathology. For many patients, this framing leaves them without a clear path forward.
It is worth noting that this picture is shifting. Multiple independent peer-reviewed studies now confirm measurable objective biological subgroups within the fibromyalgia population, including patients with documented small-fiber nerve damage, active myofascial trigger points that reproduce widespread pain patterns, and autonomic nervous system dysfunction. Fibromyalgia is not purely subjective, and it is not a single uniform condition.
NMF Science Perspective
NMF Science views fibromyalgia not as a single disease but as a syndrome label that frequently obscures highly specific, localized biological drivers. The investigational question is not "why is the brain amplifying pain signals" but rather "what physical injury pattern is constantly flooding the nervous system and creating the appearance of central sensitization."
Clinical histories across fibromyalgia patients reveal a recurring pattern. A significant portion carry a history of cumulative mechanical stress, repetitive injury, or distinct physical trauma. These physical traumas accumulate over time, manifesting as localized neuromyofascial injuries that cluster at high-stress biomechanical junctions along the spine. The key junctions NMF Science identifies are the craniocervical junction where the neck meets the skull, the lower cervical spine from C5 to T1, the thoracolumbar junction around the mid-back, and the lumbosacral junction in the lower back.
Pathology does not need to be present at all four of these junctions. Clinical observations indicate that involvement of the cervical spine combined with at least two other junction points is often sufficient to generate the widespread symptom profile that meets fibromyalgia diagnostic criteria.
When neuromyofascial fibrosis develops at these junctions, it compresses and irritates adjacent nerve roots and neural pathways. This creates subclinical neuropathies producing pain and sensory dysfunction along nerve distributions without the presence of an obvious disc herniation visible on standard imaging. The diffuse, seemingly systemic pain characteristic of fibromyalgia often originates directly from these hyper-localized mechanical injuries acting as constant physical irritants anchored along the spinal axis.
The autonomic nervous system involvement explains the non-pain symptoms that many fibromyalgia patients find most disabling. Palpitations, breathing changes, bowel and bladder dysfunction, orthostatic symptoms, and allergy-like responses are not random. Clinical observations and peer-reviewed research, including studies by Falco et al. (2023) and Puri and Lee (2021), link these autonomic symptoms directly to the cervical and thoracic neuromyofascial pathology identified in this framework.
The NMF Science approach to fibromyalgia is to reverse engineer the syndrome. Rather than treating fibromyalgia as a single entity requiring a uniform protocol, each patient's specific symptoms are traced backward to identify the precise neurological or neuromyofascial driver in the spine or limbs. That reverse-engineering process builds a patient-specific map. The map is what makes more targeted, individualized care possible.
This does not mean fibromyalgia is not real. It means the label may be obscuring something more specific that deserves a more precise investigation.
A Clinical Pattern Worth Noting
One of the most consistent clinical observations in fibromyalgia patients evaluated through the NMF Science framework is how many of their seemingly disconnected symptoms trace back to shared spinal drivers. A patient presenting with migraines, TMJ pain, carpal tunnel symptoms, sciatica, and irritable bowel syndrome may appear to have five separate conditions. Through neuromyofascial mapping, these often emerge as downstream effects of multi-level spinal pathology at the same junction points described above.
This pattern matters because it changes the investigational approach entirely. Instead of treating each symptom in isolation, the framework asks what single or multi-level spinal injury pattern could be producing all of these symptoms simultaneously. Finding that driver does not just address one complaint. It can shift the entire symptom map.
It is also important to note what the NMF Science framework does not claim. It does not assert that all fibromyalgia has the same cause, nor that every patient has identifiable spinal pathology as a driver. The framework proposes that a meaningful subset of patients diagnosed with fibromyalgia may have under-recognized neuromyofascial injury patterns that deserve more precise evaluation. That evaluation begins with mapping.
What We Investigate
→ History of significant physical trauma, accidents, repetitive strain, or chronic mechanical stress that may have initiated cumulative spinal pathology.
→ Neuromyofascial dysfunction at the four key spinal junctions: craniocervical, lower cervical (C5-T1), thoracolumbar, and lumbosacral.
→ Subclinical nerve root irritation (radicular effects) or spinal cord involvement (myelopathic effects) that may not appear as severe pathology on standard MRI.
→ Active myofascial trigger points and muscle tightness patterns that correlate with the patient's specific widespread pain distribution.
→ Small-fiber nerve involvement contributing to paresthesias, numbness, tingling, or sensory disturbance across the limbs and face.
→ Autonomic nervous system dysfunction driving palpitations, orthostatic symptoms, bowel and bladder issues, or breathing changes.
→ Whether seemingly disconnected symptoms such as migraine, TMJ pain, carpal tunnel, sciatica, and anxiety trace back to shared spinal drivers on the patient-specific neuromyofascial map.
→ Structural findings on bimanual physical examination including retrolisthesis, malrotation, loss of segmental movement, and areas of localized fibrosis that standard imaging may not capture.
→ Diagnostic imaging lag: whether the patient's symptom timeline suggests structural pathology that has not yet become visible on MRI, consistent with patterns seen in other progressive neurological conditions.
→ Treatment response patterns: whether specific symptoms improve with targeted neuromyofascial intervention, and what that response reveals about the structural drivers contributing to the overall symptom map.
Learn More About Fibromyalgia Syndrome
Below you will find our most comprehensive educational resources on Fibromyalgia Syndrome and the NMF Science investigational perspective. Explore detailed video explanations, clinical slideshows, podcasts, and in-depth articles examining what neuromyofascial mapping adds to our understanding of this complex and frequently misunderstood condition.
Videos
Slideshows
